Match Group Inc vs Vaxcyte Inc. Common Stock — how do they compare? Match Group Inc trades at $42.39 (market cap $9.72B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Match Group Inc and Vaxcyte Inc. Common Stock are close in size by market cap, and Match Group Inc pays a 1.89% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Match Group Inc for 115 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MTCH | PCVX | |
|---|---|---|
Market Cap | $9.72B | $10.51B |
Volume | 4,140,020 | 2,644,694 |
Sector | Media | Health |
52-Week High | $44.40 | $73.82 |
52-Week Low | $28.90 | $40.32 |
Typical Hold Time | 115 Days | 0 Days |
Enterprise Value | $12.69B | $9.14B |
Dividend Yield | 1.89% | — |
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $42.40, up 2.12% today, with a bullish technical signal and strong support at $41. The company reported a net income margin of 20.17% for 2025, with Q2 2026 EPS beating expectations. Operating cash flow reached $1.08B in 2025, and a $0.20 dividend is scheduled for October 2026. Recent news highlights product innovation at Tinder and growth at Hinge.
The outlook is positive with a consensus price target of $42.29, though high debt levels and competitive pressures pose risks. Analyst sentiment is bullish with 53% buy ratings. Revenue stability and margin expansion support upside potential, but investors should monitor execution on Tinder's turnaround and debt management.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →